Skip to content

Search

Showing results for "lung disease preterm"

Assessing the protective effect of influenza vaccine against laboratory confirmed influenza in hospitalised children aged 6-59 months

Influenza vaccine was offered to all children aged 6-59 months resident in Western Australia in 2008, and we wished to evaluate the effectiveness of this immunisation programme.

Pertussis (whooping cough) studies

Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: vtg@thekids.org.au The PRIME Study The

Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered

A pooled analysis was conducted of 1,257 toddlers who received a fourth dose of Haemophilus influenzae type b- Neisseria meningitidis serogroups C and...

Early diet quality in a longitudinal study of Australian children: Associations with nutrition and body mass index later in childhood and adolescence

The aims of this study were to determine whether early childhood dietary quality was associated with infant and adolescent nutrition, and body mass index.

Immunotherapy of allergic diseases by bacterial products

Allergic diseases are characterized by excessive immunoglobulin E (IgE) production, mast cell degranulation, tissue eosinophilia and mucus hypersecretion

Immediate and Longer Term Immunogenicity and Safety of a Single Dose of the Combined Haemophilus influenzae Type

Hib-primed but MenC-naive toddlers (N = 433) were randomized to receive 1 dose of Hib-MenC-TT or separate Hib-TT and MenC-CRM197 vaccines.

BANDIT trial update

The Children’s Diabetes Centre has had a few inquiries about the new BANDIT trial, based in Melbourne, and whether we are involved. Currently, the trial is only open to people who live in Victoria.The Centre is involved in other Australian studies aiming to better understand diabetes.

T2D now being diagnosed in children as young as six

Children as young as six years old are being diagnosed with type 2 diabetes, according to Perth endocrinologists who are calling for early screening of at-risk groups.

Farewell Marie-Anne

After living in Perth for the past three years, Dr Marie-Anne Burckhardt has headed back home to continue her type 1 diabetes research.